Prospective, randomised, controlled open single-centre trial on thromboembolic prophylaxis with enoxaparin in non-surgical cancer patients under systemic antineoplastic therapy.

Trial Profile

Prospective, randomised, controlled open single-centre trial on thromboembolic prophylaxis with enoxaparin in non-surgical cancer patients under systemic antineoplastic therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Dec 2012

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Acronyms VTETumor02
  • Most Recent Events

    • 17 Jan 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 20 Feb 2009 Planned end date changed from 31 Dec 2008 to 31 Dec 2010, as reported by ISRCTN: Current Controlled Trials.
    • 20 Feb 2009 Status changed from completed to unconfirmed. Status reported as 'ongoing' by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top